KR980003584A - 정제 형태인 자기 입자를 함유하는 시약 제제 - Google Patents
정제 형태인 자기 입자를 함유하는 시약 제제 Download PDFInfo
- Publication number
- KR980003584A KR980003584A KR1019970023487A KR19970023487A KR980003584A KR 980003584 A KR980003584 A KR 980003584A KR 1019970023487 A KR1019970023487 A KR 1019970023487A KR 19970023487 A KR19970023487 A KR 19970023487A KR 980003584 A KR980003584 A KR 980003584A
- Authority
- KR
- South Korea
- Prior art keywords
- magnetic particles
- sample
- tablet
- reagent formulation
- reagent
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
- G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
본 발명은 부형제의 도움으로 함께 유지되는 다수의 자기 입자를 함유하는 정제의 형태로 시료의 성분들을 결합시키기 위한 시약 제제, 및 분석 시험에 있어서, 시약 제제의 용도에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 하기 : -성분들이 본질적으로 완전하게 결합할 수 있는 표면을 갖는 다수의 자기입자, 및 -부형제로 이루어지는, 시료의 성분들을 정제에 결합시키기 위한 시약 제제.
- 제1항에 있어서, 성분의 결합을 용이하게 하는 부형제를 함유하는 것을 특징으로 하는 시약 제제.
- 제1항에 있어서, 자기 입자간 100㎛이하의 직경을 갖는 것을 특징으로 하는 시약 제제.
- 제1항 또는 제2항에 있어서, 자기 입자가 유리-유사 표면을 갖는 것을 특징으로 하는 시약 제제.
- 제1항에 있어서, 정제가 5㎎ 이상인 것을 특징으로 하는 시약 제제.
- 제4항에 있어서, 부형제가 카오트로픽 염인 것을 특징으로 하는 시약 제제.
- 핵산을 결합시키기 위한 제1항 내지 제6항 중 어느 한 항에 따른 시약 제제의 용도.
- 핵산을 정제하기 위한 제1항 내지 제6항 중 어느 한 항에 따른 시약 제제의 용도.
- 하기 : -자기 입자 및 가용성 부형제를 함유하는 정제를 시료에 첨가하고, 및 -시료중 정제를 이동시키는 것으로 이루어지는, 시료중 자기 입자의 현탁액 제조 방법.
- 하기의 단계 : -다수의 자기 입자-함유 정제를 함유하는 디스펜서를 제공하고, 및 -디스펜서를 활성화시켜 정제를 방출시키는 것으로 이루어지는, 자기 입자를 시료에 혼합시키는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19622885.9 | 1996-06-07 | ||
DE19622885A DE19622885A1 (de) | 1996-06-07 | 1996-06-07 | Reagenzzubereitung enthaltend magnetische Partikel in Form einer Tablette |
Publications (2)
Publication Number | Publication Date |
---|---|
KR980003584A true KR980003584A (ko) | 1998-03-30 |
KR100260326B1 KR100260326B1 (ko) | 2003-03-15 |
Family
ID=7796390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970023487A KR100260326B1 (ko) | 1996-06-07 | 1997-06-07 | 자기입자를함유하는정제형태의시약제제 |
Country Status (11)
Country | Link |
---|---|
US (2) | US6274386B1 (ko) |
EP (1) | EP0811694B1 (ko) |
JP (1) | JP3821541B2 (ko) |
KR (1) | KR100260326B1 (ko) |
AT (1) | ATE234366T1 (ko) |
AU (1) | AU715803B2 (ko) |
CA (1) | CA2206760C (ko) |
DE (2) | DE19622885A1 (ko) |
DK (1) | DK0811694T3 (ko) |
ES (1) | ES2195053T3 (ko) |
IL (1) | IL121008A (ko) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100463475B1 (ko) | 1995-06-08 | 2005-06-22 | 로셰 디아그노스틱스 게엠베하 | 자기성피그먼트 |
DE19520398B4 (de) * | 1995-06-08 | 2009-04-16 | Roche Diagnostics Gmbh | Magnetisches Pigment |
DE19743518A1 (de) * | 1997-10-01 | 1999-04-15 | Roche Diagnostics Gmbh | Automatisierbare universell anwendbare Probenvorbereitungsmethode |
EP2316571A3 (en) | 1998-05-01 | 2011-07-27 | Gen-Probe Incorporated | Automated diagnostic analyzer and method |
US8337753B2 (en) | 1998-05-01 | 2012-12-25 | Gen-Probe Incorporated | Temperature-controlled incubator having a receptacle mixing mechanism |
DE19836559A1 (de) | 1998-08-12 | 2000-03-23 | Antigen Gmbh | Gefäß zur Entnahme von Blut |
PT1144620E (pt) | 1998-11-30 | 2004-01-30 | Roche Diagnostics Gmbh | Perticulas magneticas para a purificacao de acidos nucleicos |
CZ20021608A3 (cs) | 1999-11-17 | 2003-06-18 | Roche Diagnostics Gmbh | Magnetické skleněné částice, metody jejich přípravy a použití |
JP4776133B2 (ja) * | 2000-02-04 | 2011-09-21 | キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング | 阻害物質に富む糞便試料及び他の生物学的材料からの核酸の単離 |
DE10006662A1 (de) * | 2000-02-15 | 2001-08-23 | Antigen Produktions Gmbh | Gefäß zur Nukleinsäureanalytik |
WO2001068599A2 (en) * | 2000-03-17 | 2001-09-20 | H. Lundbeck A/S | Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
EP1268050A2 (en) * | 2000-03-17 | 2003-01-02 | H. Lundbeck A/S | Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form |
US6602718B1 (en) | 2000-11-08 | 2003-08-05 | Becton, Dickinson And Company | Method and device for collecting and stabilizing a biological sample |
AU2003219759B2 (en) * | 2002-02-14 | 2011-01-20 | Veridex, Llc | Methods and algorithms for cell enumeration in a low-cost cytometer |
US9267167B2 (en) | 2004-06-28 | 2016-02-23 | Becton, Dickinson And Company | Dissolvable films and methods including the same |
US20080070308A1 (en) * | 2004-06-28 | 2008-03-20 | Thomas Ruhland | Portous Article For Delivering Chemical Substances |
US8189899B2 (en) * | 2004-07-30 | 2012-05-29 | Veridex, Llc | Methods and algorithms for cell enumeration in a low-cost cytometer |
KR100850430B1 (ko) * | 2006-12-11 | 2008-08-05 | (주)바이오니아 | 입자상 물질을 사용하는 핵산 분리 방법 및 핵산 분리용조성물 |
EP2143496A1 (en) * | 2008-07-09 | 2010-01-13 | F. Hoffmann-Roche AG | Lysis reagent formulation containing magnetic particles in tablet form |
JP2013503352A (ja) * | 2009-08-31 | 2013-01-31 | エムバイオ ダイアグノスティクス,インコーポレイティド | 統合されたサンプル調製及び検体検出 |
TWI407994B (zh) | 2009-10-22 | 2013-09-11 | Ind Tech Res Inst | 分離核酸的方法、試劑及套組 |
CN111757934A (zh) | 2017-12-21 | 2020-10-09 | 豪夫迈·罗氏有限公司 | 通过单向双重探针引物延伸的靶标富集 |
EP3749782B1 (en) | 2018-02-05 | 2022-11-02 | F. Hoffmann-La Roche AG | Generation of single-stranded circular dna templates for single molecule sequencing |
CN111936635A (zh) | 2018-03-02 | 2020-11-13 | 豪夫迈·罗氏有限公司 | 用于单分子测序的单链环状dna模板的产生 |
WO2020058389A1 (en) | 2018-09-21 | 2020-03-26 | F. Hoffmann-La Roche Ag | System and method for modular and combinatorial nucleic acid sample preparation for sequencing |
WO2021053008A1 (en) | 2019-09-20 | 2021-03-25 | F. Hoffmann-La Roche Ag | Immune repertoire profiling by primer extension target enrichment |
EP4179113A1 (en) | 2020-07-08 | 2023-05-17 | F. Hoffmann-La Roche AG | Targeted depletion of non-target library molecules using poison primers during target capture of next-generation sequencing libraries |
US20220177950A1 (en) | 2020-12-03 | 2022-06-09 | Roche Sequencing Solutions, Inc. | Whole transcriptome analysis in single cells |
WO2024013241A1 (en) | 2022-07-14 | 2024-01-18 | F. Hoffmann-La Roche Ag | Variant allele enrichment by unidirectional dual probe primer extension |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3981776A (en) * | 1967-02-16 | 1976-09-21 | Rolf Saxholm | Magnetically responsive, biologically active substance and associated methods and apparatus |
US4169804A (en) * | 1976-08-19 | 1979-10-02 | Minnesota Mining And Manufacturing Company | Magnetically responsive composite microparticle |
US4115534A (en) * | 1976-08-19 | 1978-09-19 | Minnesota Mining And Manufacturing Company | In vitro diagnostic test |
US4233169A (en) * | 1979-04-13 | 1980-11-11 | Corning Glass Works | Porous magnetic glass structure |
US4343901A (en) | 1980-10-22 | 1982-08-10 | Uop Inc. | Magnetic support matrix for enzyme immobilization |
US4483920A (en) * | 1982-05-17 | 1984-11-20 | Hahnemann University | Immobilization of message RNA directly from cells onto filter material |
US4735796A (en) * | 1983-12-08 | 1988-04-05 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
US5746999A (en) * | 1984-11-23 | 1998-05-05 | Schering Aktiengesellschaft | Magnetic particles for diagnostic purposes |
US5597531A (en) * | 1985-10-04 | 1997-01-28 | Immunivest Corporation | Resuspendable coated magnetic particles and stable magnetic particle suspensions |
US4820627A (en) * | 1986-03-24 | 1989-04-11 | Em Diagnostic Systems, Inc. | Method of preparing particles suitable for tabletting into diagnostic reagents |
US5009994A (en) * | 1986-03-24 | 1991-04-23 | Em Diagnostic Systems, Inc. | Particles containing mannitol suitable for tabletting into diagnostic reagents |
US4712310A (en) * | 1986-09-15 | 1987-12-15 | E. I. Du Pont De Nemours And Company | Co-spray technique |
DK269889A (da) * | 1988-06-06 | 1989-12-07 | Photest Diagnostics Inc | Heterogen immunoassay |
AU640626B2 (en) * | 1988-11-21 | 1993-09-02 | Dynal As | Nucleic acid probes |
US5512439A (en) * | 1988-11-21 | 1996-04-30 | Dynal As | Oligonucleotide-linked magnetic particles and uses thereof |
US5234809A (en) * | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
JPH04323560A (ja) * | 1991-04-22 | 1992-11-12 | Nippon Telegr & Teleph Corp <Ntt> | レーザ磁気免疫測定に用いられる磁性微粒子標識材料並びに検体調整方法 |
DE4406139A1 (de) * | 1994-02-25 | 1995-08-31 | Matthias Werner | Magnetische Depotarzneimittel für die perorale Applikation mit verbesserter Resorption der Wirkstoffe |
US5593824A (en) * | 1994-09-02 | 1997-01-14 | Pharmacia Biotech, Inc. | Biological reagent spheres |
DE19520398B4 (de) * | 1995-06-08 | 2009-04-16 | Roche Diagnostics Gmbh | Magnetisches Pigment |
-
1996
- 1996-06-07 DE DE19622885A patent/DE19622885A1/de not_active Withdrawn
-
1997
- 1997-05-29 AU AU23705/97A patent/AU715803B2/en not_active Ceased
- 1997-06-04 CA CA002206760A patent/CA2206760C/en not_active Expired - Lifetime
- 1997-06-05 IL IL12100897A patent/IL121008A/en not_active IP Right Cessation
- 1997-06-05 JP JP16504297A patent/JP3821541B2/ja not_active Expired - Lifetime
- 1997-06-06 AT AT97109177T patent/ATE234366T1/de active
- 1997-06-06 US US08/870,385 patent/US6274386B1/en not_active Expired - Lifetime
- 1997-06-06 DE DE59709467T patent/DE59709467D1/de not_active Expired - Lifetime
- 1997-06-06 DK DK97109177T patent/DK0811694T3/da active
- 1997-06-06 ES ES97109177T patent/ES2195053T3/es not_active Expired - Lifetime
- 1997-06-06 EP EP97109177A patent/EP0811694B1/de not_active Expired - Lifetime
- 1997-06-07 KR KR1019970023487A patent/KR100260326B1/ko not_active IP Right Cessation
-
2001
- 2001-06-29 US US09/893,533 patent/US6746874B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL121008A0 (en) | 1997-11-20 |
US6274386B1 (en) | 2001-08-14 |
US20010046714A1 (en) | 2001-11-29 |
CA2206760A1 (en) | 1997-12-07 |
ES2195053T3 (es) | 2003-12-01 |
ATE234366T1 (de) | 2003-03-15 |
CA2206760C (en) | 2003-08-19 |
JPH1062422A (ja) | 1998-03-06 |
DK0811694T3 (da) | 2003-07-14 |
EP0811694A3 (de) | 1999-01-13 |
IL121008A (en) | 2001-08-08 |
JP3821541B2 (ja) | 2006-09-13 |
EP0811694A2 (de) | 1997-12-10 |
US6746874B2 (en) | 2004-06-08 |
KR100260326B1 (ko) | 2003-03-15 |
DE59709467D1 (de) | 2003-04-17 |
AU715803B2 (en) | 2000-02-10 |
DE19622885A1 (de) | 1997-12-11 |
EP0811694B1 (de) | 2003-03-12 |
AU2370597A (en) | 1997-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR980003584A (ko) | 정제 형태인 자기 입자를 함유하는 시약 제제 | |
CA2003508A1 (en) | Monodisperse superparamagnetic particles for use in nucleic acid analyses | |
CA2223821A1 (en) | Magnetic particles with a glass surface and their use | |
AR012717A1 (es) | Trihidrato de la sal de magnesio de s-omeprazol, proceso para su preparacion, composicion farmaceutica, y uso de dicho trihidrato para la fabricacion de medicamentos. | |
DE69509671D1 (de) | Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung | |
MA26654A1 (fr) | Pyrrolopyrimidines nouvelles procede pour leur preparation et compositions pharmaceutiques les contenant | |
AU7575291A (en) | Process and composition for performing dna assays | |
FR2778100B1 (fr) | Nouvelles microspheres a base de poly(methylidene malonate), leur procede de preparation et compositions pharmaceutiques les contenant | |
DE69002863D1 (de) | Galliumteilchen enthaltende flüssige Suspensionszusammensetzung und Verfahren zu ihrer Herstellung. | |
DE59008160D1 (de) | Feste pharmazeutische Präparate und Verfahren zu ihrer Herstellung. | |
AU1906388A (en) | Polysiloxane based magnetisable microspheres, and process for their preparation | |
DE69012650D1 (de) | Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung. | |
DE60015649D1 (de) | Polyamidsäure und feine dispergierte Teilchen enthaltende Zusammensetzung und Verfahren zu ihrer Herstellung | |
AU9372698A (en) | An (in vitro) activity assay for human hepatits b virus (hbv) dna polymerase, the use of such an assay to assay activity of various serum samples and to screen for inhibitors of the hbv dna polymerase and a method of producing hbv dna polymerase | |
DE69020119T2 (de) | Verfahren zur Herstellung von hochreiner Naphthalin-2,6-Dicarbonsäure. | |
DE68923993T2 (de) | Polymaleimid-Verbindungen und Verfahren zu ihrer Herstellung. | |
HU895450D0 (en) | Process for the preparation of antiflatulent pharmaceutical composition containing activated polydimethylsiloxane in solid dispersion | |
BR9004394A (pt) | Substratos em forma de plaquetas sistema de latex processo para sua preparacao,emprego e formulacoes | |
EP0301899A3 (en) | Nucleic acid capture reagent | |
FR2755438B1 (fr) | Compose, procede pour sa preparation et composition pharmaceutique le contenant | |
AU631407B2 (en) | Magnesium folates, process for their preparation and pharmaceutical compositions | |
DE3788489T2 (de) | Fe7C3-enthaltende Partikel und Verfahren zu ihrer Herstellung. | |
DE69600338D1 (de) | Verfahren zur Herstellung von Naphthalin-2,6-dicarbonsäure und ihrem Ester | |
AU2573695A (en) | Process for the preparation of magnetic particles used in biological analyses | |
MA26477A1 (fr) | Compose pharmaceutique nouveau, procede pour sa preparation et composition pharmaceutique le contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |